Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
Aim : To study in vivo the peculiarities of changes of iron metabolism and antioxidant system in dynamics of growth of Guerin carcinoma with different sensitivity to cisplatin. Materials and Methods: In order to evaluate the content of metallothionein-1 (MT-1) in tumor homogenates and blood serum of...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2014 |
| Main Authors: | Chekhun, V.F., Lozovska, Y.V., Burlaka, A.P., Lukyanova, N.Y., Todor, I.N., Naleskina, L.A. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2014
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145366 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin / V.F. Chekhun, Y.V. Lozovska, A.P. Burlaka, N.Y. Lukyanova, I.N. Todor, L.A. Naleskina // Experimental Oncology. — 2014. — Т. 36, № 3. — С. 196-201. — Бібліогр.: 26 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: V. F. Chekhun, et al.
Published: (2014)
by: V. F. Chekhun, et al.
Published: (2014)
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)
by: Chekhun, V.F., et al.
Published: (2013)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)
by: Todor, I.N., et al.
Published: (2012)
Alteration in lipid composition of plasma membranes of sensitive and resistant Guerin carcinoma cells due to the action of free and liposomal form of cisplatin
by: Naleskina, L.A., et al.
Published: (2013)
by: Naleskina, L.A., et al.
Published: (2013)
Biodistribution analysis of cisplatin in liposomal form in animals with cisplatinresistant and cisplatin-sensitive carcinoma
by: Nosko, M.M., et al.
Published: (2010)
by: Nosko, M.M., et al.
Published: (2010)
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Ultrastructural and some functional changes in tumor cells treated with stabilized iron oxide nanoparticles
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Ultrastructural changes in tumor cells treated with liposomal forms of anticancer drugs
by: Yurchenko, O.V., et al.
Published: (2010)
by: Yurchenko, O.V., et al.
Published: (2010)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Clinical significance of hormonal receptor status of malignant ovarian tumors
by: Tkalia, I.G., et al.
Published: (2014)
by: Tkalia, I.G., et al.
Published: (2014)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
Enterosorption as a method to decrease the systemic toxicity of cisplatin
by: Sakhno, L.A., et al.
Published: (2013)
by: Sakhno, L.A., et al.
Published: (2013)
Modifying effects of 5-azacytidine on metal-containing proteins profile in guerin carcinoma with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Association of cd44⁺cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
The use of nanoferromagnetics to increase the cytotoxic effect of antitumor drugs
by: Chekhun, V.F., et al.
Published: (2009)
by: Chekhun, V.F., et al.
Published: (2009)
The state of bone metabolism in lung cancer patients
by: Dumansky, Y.V., et al.
Published: (2018)
by: Dumansky, Y.V., et al.
Published: (2018)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Correlation of nucleotides and carbohydrates metabolism with pro-oxidant and antioxidant systems of erythrocytes depending on age in patients with colorectal cancer
by: Zuikov, S.A., et al.
Published: (2014)
by: Zuikov, S.A., et al.
Published: (2014)
Expression of CD40 by the cells of benign and malignant breast tumors and antitumor action of autologous lymphocytes against chemoresistant and chemosensitive tumors
by: Bereznaya, N.M., et al.
Published: (2008)
by: Bereznaya, N.M., et al.
Published: (2008)
The study of possibility to elevate antitumor activity and decrease of systemic toxic effects of cisplatin by its binding with deliganded albumin
by: Sakhno, L.A., et al.
Published: (2006)
by: Sakhno, L.A., et al.
Published: (2006)
In VIVO anti-tumor activities of gelatin
by: Inamura, Y., et al.
Published: (2009)
by: Inamura, Y., et al.
Published: (2009)
Pharmacological effect of aminoferrocene in mice with L1210 leukemia
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Combined antiproliferative activity of imatinib mesylate (STI-571) with radiation or cisplatin in vitro
by: Yerushalmi, R., et al.
Published: (2007)
by: Yerushalmi, R., et al.
Published: (2007)
Disordered redox metabolism of brain cells in rats exposed to low doses of ionizing radiation or uhf electromagnetic radiation
by: Burlaka, A.P., et al.
Published: (2016)
by: Burlaka, A.P., et al.
Published: (2016)
Effects of radical oxygen species and no: formation of intracellular hypoxia and activation of matrix metalloproteinases in tumor tissues
by: Burlaka, A.P., et al.
Published: (2006)
by: Burlaka, A.P., et al.
Published: (2006)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
Molecular-genetic models for prognosis of development of tumors of reproductive system in women with family history of cancer
by: Paliychuk, O.V., et al.
Published: (2018)
by: Paliychuk, O.V., et al.
Published: (2018)
Expression of cancer-associated genes in prostate tumors
by: Rosenberg, E.E., et al.
Published: (2017)
by: Rosenberg, E.E., et al.
Published: (2017)
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats
by: Tkalia, I.G., et al.
Published: (2015)
by: Tkalia, I.G., et al.
Published: (2015)
Expression of steroid and peptide hormone receptors, metabolic enzymes and EMT-related genes in prostate tumors in relation to the presence of the TMPRSS2/ERG fusion
by: Gerashchenko, G.V., et al.
Published: (2018)
by: Gerashchenko, G.V., et al.
Published: (2018)
O₂·- and NO-associated mechanisms of selective action of redox-active cobalt complexes on tumor tissue
by: Ganusevich, I.I., et al.
Published: (2007)
by: Ganusevich, I.I., et al.
Published: (2007)
Synergic carcinostatic effects of ascorbic acid and hyperthermia on Ehrlich ascites tumor cell
by: Saitoh, Y., et al.
Published: (2015)
by: Saitoh, Y., et al.
Published: (2015)
Similar Items
-
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: V. F. Chekhun, et al.
Published: (2014) -
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor
by: Tkalia, I.G., et al.
Published: (2014) -
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013) -
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015) -
The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
by: Todor, I.N., et al.
Published: (2012)